Pfizer Zithromax 250mg Azithromycin

Zithromax is a widely recognized brand name for the antibiotic azithromycin, which was originally developed by the Croatian pharmaceutical company Pliva and later brought to the global market through a licensing agreement with Pfizer. The product shown in the image is 250 mg tablets, used to treat various bacterial infections.

While Pfizer is the original brand owner and developer for the Western market, the manufacturing of Zithromax occurs across a global network of specialized pharmaceutical facilities to meet international demand. Consequently, the product is indicated as being made in multiple countries depending on the specific regional shipment. Pfizer, a titan in the global healthcare industry headquartered in New York, remains the ultimate owner and controller of the brand identity and distribution rights.